ProShare Advisors’s Mersana Therapeutics MRSN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-28,784
| Closed | -$9.91K | – | 2145 |
|
|
2025
Q1 | $9.91K | Sell |
28,784
-9,015
| -24% | -$3.1K | ﹤0.01% | 2068 |
|
|
2024
Q4 | $54.1K | Buy |
37,799
+16,364
| +76% | +$23.4K | ﹤0.01% | 2168 |
|
|
2024
Q3 | $40.5K | Buy |
21,435
+6,585
| +44% | +$12.4K | ﹤0.01% | 2000 |
|
|
2024
Q2 | $29.8K | Sell |
14,850
-5,069
| -25% | -$10.2K | ﹤0.01% | 1786 |
|
|
2024
Q1 | $89.2K | Buy |
19,919
+1,569
| +9% | +$7.03K | ﹤0.01% | 1839 |
|
|
2023
Q4 | $42.6K | Sell |
18,350
-3,200
| -15% | -$7.42K | ﹤0.01% | 1878 |
|
|
2023
Q3 | $27.4K | Buy |
21,550
+1,099
| +5% | +$1.4K | ﹤0.01% | 1766 |
|
|
2023
Q2 | $67.3K | Buy |
20,451
+2,069
| +11% | +$6.81K | ﹤0.01% | 1744 |
|
|
2023
Q1 | $75.6K | Sell |
18,382
-1,779
| -9% | -$7.31K | ﹤0.01% | 1631 |
|
|
2022
Q4 | $118K | Buy |
20,161
+2,051
| +11% | +$12K | ﹤0.01% | 1618 |
|
|
2022
Q3 | $122K | Buy |
18,110
+711
| +4% | +$4.79K | ﹤0.01% | 1514 |
|
|
2022
Q2 | $80K | Sell |
17,399
-4,649
| -21% | -$21.4K | ﹤0.01% | 1645 |
|
|
2022
Q1 | $88K | Sell |
22,048
-3,719
| -14% | -$14.8K | ﹤0.01% | 2056 |
|
|
2021
Q4 | $161K | Buy |
25,767
+1,268
| +5% | +$7.92K | ﹤0.01% | 2107 |
|
|
2021
Q3 | $231K | Sell |
24,499
-5,867
| -19% | -$55.3K | ﹤0.01% | 1714 |
|
|
2021
Q2 | $412K | Buy |
30,366
+6,587
| +28% | +$89.4K | ﹤0.01% | 1676 |
|
|
2021
Q1 | $385K | Buy |
23,779
+1,415
| +6% | +$22.9K | ﹤0.01% | 1633 |
|
|
2020
Q4 | $595K | Buy |
+22,364
| New | +$595K | ﹤0.01% | 1153 |
|
|
2018
Q4 | – | Sell |
-10,982
| Closed | -$110K | – | 1654 |
|
|
2018
Q3 | $110K | Sell |
10,982
-282
| -3% | -$2.83K | ﹤0.01% | 1671 |
|
|
2018
Q2 | $201K | Sell |
11,264
-686
| -6% | -$12.2K | ﹤0.01% | 1606 |
|
|
2018
Q1 | $188K | Sell |
11,950
-1,058
| -8% | -$16.6K | ﹤0.01% | 1563 |
|
|
2017
Q4 | $214K | Buy |
+13,008
| New | +$214K | ﹤0.01% | 1605 |
|